Morbidity of different treatment modalities in advanced Carcinoma larynx


  • Md Sirajul Islam Mahfuz Senior Consultant, ENT, 250 bed General Hospital. Gopalganj
  • Belayat Hossain Siddiquee Professor, Head-Neck Surgery Department of Otolaryngology & Head-Neck Surgery Bangabandhu Sheikh Mujib Medical University (BSMMU). Dhaka
  • A Allam Choudhury Associate Professor, Department of Otolaryngology & Head-Neck Surgery, BSMMU, Dhaka
  • Shaikh Muniruddin Ahmad Registrar. Department of Otolaryngology & Head-Neck Surgery, Dhaka Medical College Hospital. Dhaka



Carcinoma larynx, Treatment modalities, morbidity of treatment in laryngeal carcinoma


Objectives: To evaluate morbidity of different modalities of treatment in advanced carcinoma larynx (stage III and IV).

Methods: It was a cross sectional study conducted among selected 70 patients of advanced carcinoma larynx treated by different modalities of treatment from April 2009 to April 2010 in different tertiary hospitals in Dhaka.

Results:The age of the patients ranged from 30 to 79 years (mean ± SD = 54±10.94), maximum age incidence 5th decade. Almost all were male, habituated in betel nut and leaves chewing and smoking. Mostly (60%) from poor socioeconomic group. 70% cases were supraglottic and 30% cases were glottic carcinoma. Nature of lesion was exophytic 71.43% and ulcerative 28.57%. 22.86% had neck node metastasis. Histopathologically 60% were moderately differentiated and grade II squamous cell carcinoma (SCC). In the total laryngectomy patient pharyngocuteneous fistula (30%), wound infection (10%), haematoma (10%), stomal recurrence (10%), stenosis is tracheostomy (10%), recurrent chest infection (10%) and pharyngeal stenosis (10%) were the morbidities. Mucositis or painful erythematous reaction in larynx and pharynx (95%), periconditis (2.5%), dryness of mouth and throat (100%), loss of test (100%), subcutaneous fibrosis (32.5%), nausea vomiting, skin rashes and alopecia (100%) were the morbidities of chemoradiotherapy and radiotherapy. After analysis the major and minor morbidities of different, modalities of treatment there was no significant (p > 0.05) difference among those modalities.

Conclusion: The difference between the morbidity of single modality and combined modalities had not significant. So the combined modalities approach may be advocated for the treatment of advanced carcinoma larynx where required.


Bangladesh J Otorhinolaryngol; October 2014; 20(2): 66-74


Download data is not yet available.




How to Cite

Mahfuz, M. S. I., Siddiquee, B. H., Choudhury, A. A., & Ahmad, S. M. (2015). Morbidity of different treatment modalities in advanced Carcinoma larynx. Bangladesh Journal of Otorhinolaryngology, 20(2), 66–74.



Original Articles